Localized Unresectable Neuroblastoma: Clinical Trials

3 trials for Localized Unresectable Neuroblastoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3

Follow Localized Unresectable Neuroblastoma: new trials by email Literature Review of Localized Unresectable Neuroblastoma trials Research Report on Localized Unresectable Neuroblastoma

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin
3-Dimensional Conformal Radiation Therapy, Autologous Hematopoietic Stem Cell Transplantation, Busulfan - Ganglioneuroblastoma, Localized Resectable Neuroblastoma
Phase 1CompletedChildren's Oncology Group992011-12-212026-01-23
Vorinostat and Isotretinoin in Treating Patients With High-Risk Refractory or Recurrent Neuroblastoma
Isotretinoin, Laboratory Biomarker Analysis, Pharmacological Study - Localized Unresectable Neuroblastoma, Recurrent Neuroblastoma
Phase 1CompletedNational Cancer Institute (NCI)292010-12-012015-11-24
R(+)XK469 in Treating Patients With Advanced Neuroblastoma
R(+)XK469 - Disseminated Neuroblastoma, Localized Unresectable Neuroblastoma
Phase 1CompletedNational Cancer Institute (NCI)852001-12-012013-12-16

Narrower conditions

Neuroblastoma (3)  ·  Ganglioneuroblastoma (1)

Broader conditions

Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms, Germ Cell and Embryonal (3)  ·  Neoplasms, Glandular and Epithelial (3)  ·  Neoplasms, Nerve Tissue (3)  ·  Neoplasms, Neuroepithelial (3)  ·  Neuroectodermal Tumors (3)  ·  Neuroectodermal Tumors, Primitive (3)  ·  Neuroectodermal Tumors, Primitive, Peripheral (3)

Interventions

Isotretinoin (2)  ·  1,2-diaminocyclohexaneplatinum II citrate (1)  ·  3-Iodobenzylguanidine (1)  ·  Busulfan (1)  ·  Cisplatin (1)  ·  Congresses as Topic (1)  ·  Cyclophosphamide (1)  ·  Doxorubicin (1)  ·  Melphalan (1)  ·  Platinum (1)  ·  Radiation (1)  ·  Radiotherapy, Conformal (1)  ·  Radiotherapy, Intensity-Modulated (1)  ·  Stem Cell Transplantation (1)  ·  Topotecan (1)

Sponsors

National Cancer Institute (NCI) (2)  ·  Children's Oncology Group (1)

Countries

United States (3)  ·  Canada (1)

Top investigators

Brian D Weiss (1)  ·  Julie Park (1)  ·  Susan Cohn (1)

Results publications

PMID 34028986

NIH funding

P01CA081403 (1), U01CA069852 (1), U10CA098543 (1), U10CA180886 (1)